Insight Molecular Diagnostics Long Term Debt 2014-2025 | IMDX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Insight Molecular Diagnostics long term debt from 2014 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Insight Molecular Diagnostics long term debt from 2014 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$45.9B
Doximity (DOCS)	$11.3B
Hims & Hers Health (HIMS)	$10.7B
Tempus AI (TEM)	$10B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.7B
Hinge Health (HNGE)	$3.7B
Privia Health (PRVA)	$2.5B
Schrodinger (SDGR)	$1.7B
Clover Health Investments (CLOV)	$1.6B
Phreesia (PHR)	$1.6B
Enovis (ENOV)	$1.5B
Azenta (AZTA)	$1.4B
10x Genomics (TXG)	$1.4B
Omnicell (OMCL)	$1.3B
Evolent Health (EVH)	$1.1B
Claritev (CTEV)	$705M
Fulgent Genetics (FLGT)	$540M
Veradigm (MDRX)	$498M
Standard BioTools (LAB)	$479M
Butterfly Network (BFLY)	$465M
Talkspace (TALK)	$427M
TruBridge (TBRG)	$337M
Outset Medical (OM)	$310M
Nyxoah SA (NYXH)	$270M
Health Catalyst (HCAT)	$269M
SOPHiA GENETICS SA (SOPH)	$233M
CapsoVision (CV)	$206M
Zepp Health (ZEPP)	$187M
KORU Medical Systems (KRMD)	$160M